PT1245565E - Derivados de indenoindolonas processo para a sua preparacao e as composicoes farmaceuticas que os contem - Google Patents

Derivados de indenoindolonas processo para a sua preparacao e as composicoes farmaceuticas que os contem

Info

Publication number
PT1245565E
PT1245565E PT02290668T PT02290668T PT1245565E PT 1245565 E PT1245565 E PT 1245565E PT 02290668 T PT02290668 T PT 02290668T PT 02290668 T PT02290668 T PT 02290668T PT 1245565 E PT1245565 E PT 1245565E
Authority
PT
Portugal
Prior art keywords
indenoindolon
contain
preparation
pharmaceutical compositions
derivatives process
Prior art date
Application number
PT02290668T
Other languages
English (en)
Portuguese (pt)
Inventor
Michel Wierzbicki
Marie-Francoise Boussard
Philippe Delagrange
Anne Rousseau
Jean-Albert Boutin
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of PT1245565E publication Critical patent/PT1245565E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Child & Adolescent Psychology (AREA)
  • Anesthesiology (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PT02290668T 2001-03-19 2002-03-18 Derivados de indenoindolonas processo para a sua preparacao e as composicoes farmaceuticas que os contem PT1245565E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0103667A FR2822153B1 (fr) 2001-03-19 2001-03-19 Nouveaux derives d'indenoindolones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
PT1245565E true PT1245565E (pt) 2003-12-31

Family

ID=8861264

Family Applications (1)

Application Number Title Priority Date Filing Date
PT02290668T PT1245565E (pt) 2001-03-19 2002-03-18 Derivados de indenoindolonas processo para a sua preparacao e as composicoes farmaceuticas que os contem

Country Status (24)

Country Link
US (1) US6844445B2 (enEXAMPLES)
EP (1) EP1245565B1 (enEXAMPLES)
JP (1) JP3886829B2 (enEXAMPLES)
KR (1) KR100453979B1 (enEXAMPLES)
CN (1) CN1185214C (enEXAMPLES)
AR (1) AR034861A1 (enEXAMPLES)
AT (1) ATE250578T1 (enEXAMPLES)
AU (1) AU780027B2 (enEXAMPLES)
BR (1) BR0200871A (enEXAMPLES)
CA (1) CA2378628C (enEXAMPLES)
DE (1) DE60200041T2 (enEXAMPLES)
DK (1) DK1245565T3 (enEXAMPLES)
EA (1) EA004711B1 (enEXAMPLES)
ES (1) ES2207629T3 (enEXAMPLES)
FR (1) FR2822153B1 (enEXAMPLES)
HK (1) HK1049159B (enEXAMPLES)
HU (1) HU226674B1 (enEXAMPLES)
MX (1) MXPA02002816A (enEXAMPLES)
NO (1) NO321890B1 (enEXAMPLES)
NZ (1) NZ517855A (enEXAMPLES)
PL (1) PL352866A1 (enEXAMPLES)
PT (1) PT1245565E (enEXAMPLES)
SI (1) SI1245565T1 (enEXAMPLES)
ZA (1) ZA200202220B (enEXAMPLES)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006047231B4 (de) * 2006-10-04 2009-02-12 Hemmerling, Hans-Jörg, Dr. Substituierte Indeno[1,2-b]indolderivate als neue Hemmstoffe der Protein Kinase CK2 und ihre Verwendung als Tumor Therapeutika, Cytostatika und Diagnostika
ES2580702B1 (es) 2015-02-25 2017-06-08 Palobiofarma, S.L. Derivados de 2-aminopiridina como antagonistas del receptor A2b de adenosina y ligandos del receptor MT3 de melatonina
WO2019058393A1 (en) 2017-09-22 2019-03-28 Jubilant Biosys Limited HETEROCYCLIC COMPOUNDS AS INHIBITORS OF PAD
FI3697785T3 (fi) 2017-10-18 2023-04-03 Jubilant Epipad LLC Imidatsopyridiiniyhdisteitä pad:n estäjinä
US11629135B2 (en) 2017-11-06 2023-04-18 Jubilant Prodell Llc Pyrimidine derivatives as inhibitors of PD1/PD-L1 activation
SG11202004537UA (en) 2017-11-24 2020-06-29 Jubilant Episcribe Llc Heterocyclic compounds as prmt5 inhibitors
SG11202008950PA (en) 2018-03-13 2020-10-29 Jubilant Prodel LLC Bicyclic compounds as inhibitors of pd1/pd-l1 interaction/activation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT99232A (pt) * 1990-10-16 1992-09-30 Univ Bath Processo de preparacao de compostos de indeno-indolo de composicoes farmaceuticas, e de estabilizacao de compostos susceptiveis de deterioracao oxidadtiva

Also Published As

Publication number Publication date
AU780027B2 (en) 2005-02-24
FR2822153A1 (fr) 2002-09-20
HU0201024D0 (enEXAMPLES) 2002-05-29
MXPA02002816A (es) 2004-11-12
CA2378628A1 (fr) 2002-09-19
BR0200871A (pt) 2003-01-07
CA2378628C (fr) 2007-07-10
EA200200263A3 (ru) 2002-12-26
JP2002322150A (ja) 2002-11-08
JP3886829B2 (ja) 2007-02-28
HUP0201024A2 (hu) 2002-11-28
AU2746902A (en) 2002-09-26
NO321890B1 (no) 2006-07-17
HK1049159B (zh) 2005-07-29
FR2822153B1 (fr) 2003-10-31
CN1375490A (zh) 2002-10-23
ATE250578T1 (de) 2003-10-15
KR100453979B1 (ko) 2004-10-20
DE60200041D1 (de) 2003-10-30
NO20021330D0 (no) 2002-03-18
PL352866A1 (en) 2002-09-23
EA200200263A2 (ru) 2002-10-31
US6844445B2 (en) 2005-01-18
HK1049159A1 (en) 2003-05-02
DK1245565T3 (da) 2004-01-12
SI1245565T1 (en) 2003-12-31
KR20020074420A (ko) 2002-09-30
ZA200202220B (en) 2002-10-10
NO20021330L (no) 2002-09-20
EA004711B1 (ru) 2004-06-24
ES2207629T3 (es) 2004-06-01
NZ517855A (en) 2002-10-25
CN1185214C (zh) 2005-01-19
AR034861A1 (es) 2004-03-24
EP1245565A1 (fr) 2002-10-02
US20020173531A1 (en) 2002-11-21
HUP0201024A3 (en) 2003-12-29
DE60200041T2 (de) 2004-06-09
HU226674B1 (en) 2009-06-29
EP1245565B1 (fr) 2003-09-24

Similar Documents

Publication Publication Date Title
PT1150961E (pt) Derivados do acido pirazolecarboxilico processo para a sua preparacao e as composicoes farmaceuticas que os contem
PT1339675E (pt) Compostos bisarilo orto, meta-substituidos, processo para a sua preparacao, sua utilizacao como medicamentos e composicoes farmaceuticas que os contem
PT1192122E (pt) Derivados de benzeno processo para a sua preparacao e composicoes farmaceuticas que os contem
BR0017030B1 (pt) derivados de tiazolilamida, processo para sua preparação, composição farmacêutica que os compreende e uso dos mesmos
PT1152765E (pt) Etanolato de azitromicina, processo de preparacao e composicoes farmaceuticas que os contem
PT1202965E (pt) Derivados de indol processos para a sua preparacao composicoes farmaceuticas que os contem e a sua aplicacao
BR9801606B1 (pt) composto, processo para sua preparação, substáncia farmacêutica, uso do composto e processo para a produção de uma substáncia farmacêutica.
BR9910900B1 (pt) compostos derivados de isotiazol, processo para sua preparação e composição farmacêutica dos mesmos
PT912613E (pt) Polissacaridos sinteticos processo para a sua preparacao e composicoes farmaceuticas que os contem
PT973763E (pt) Novos derivados do 2-(iminometil)amino-fenilo, sua preparacao, sua aplicacao na qualidade de medicamentos e composicoes farmaceuticas que os contem
PT1122254E (pt) Derivados de 4-sulfonamidas piperidina, processo para a sua preparacao e as composicoes farmaceuticas que os contem
PT1560826E (pt) Compostos piridopirimidinona, seus processos de preparacao e composicoes farmaceuticas que os contem
PT1118610E (pt) Novos derivados de benzeno-sulfonamida processo para a sua preparacao e as composicoes farmaceuticas que os contem
PT1187847E (pt) Derivados de estreptograminas sua preparacao e as composicoes que os contem
PT1049721E (pt) Polissacaridos de sintese processo para a sua preparacao e composicoes farmaceuticas que os contem
PT1049706E (pt) Novos penta-sacaridos os respectivos metodos de producao e as composicoes farmaceuticas que os contem
BR1100524A (pt) Compostos, processo para sua preparação; compostos intermediários para os mesmos, e composições farmacêuticas
PT1401397E (pt) Formulacao farmaceutica com sabor mascarado e processo para a sua preparacao
PT1275647E (pt) Derivados de octa-hidro-2h-pirido¬1,2-a|pirazina processo para a sua preparacao e as composicoes farmaceuticas que os contem
PT1241169E (pt) Derivados de isoindoloindolona processo para a sua preparacao e as composicoes farmaceuticas que os contem
PT1245565E (pt) Derivados de indenoindolonas processo para a sua preparacao e as composicoes farmaceuticas que os contem
PT1395582E (pt) Novos derivados de piperidinocarboxamida, metodo para a sua preparacao e composicoes farmaceuticas que os contem
PT1176148E (pt) Novos derivados de benzotiadiazina processo para a sua preparacao e as composicoes farmaceuticas que os contem
PT1411057E (pt) Derivados de [3,4-a:3,4-c]carbazole processo para a sua preparacao e as composicoes farmaceuticas que os contem
PT1224210E (pt) Compostos monociclicos basicos tendo accao antagonista de nk-2 processos para a sua preparacao e formulacoes que os contem